Russell Investments Group, Ltd. Alkermes Plc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 11,664 shares of ALKS stock, worth $346,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,664
Previous 17,484 33.29%
Holding current value
$346,537
Previous $421,000 22.57%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$23.01 - $28.55 $133,918 - $166,161
-5,820 Reduced 33.29%
11,664 $326,000
Q2 2024

Aug 08, 2024
SELL
$23.21 - $27.24 $1.99 Million - $2.34 Million
-85,920 Reduced 83.09%
17,484 $421,000
Q1 2024

May 08, 2024
SELL
$26.4 - $32.56 $51,559 - $63,589
-1,953 Reduced 1.85%
103,404 $2.8 Million
Q4 2023

Feb 05, 2024
SELL
$23.37 - $28.68 $1.91 Million - $2.34 Million
-81,673 Reduced 43.67%
105,357 $2.92 Million
Q3 2023

Nov 13, 2023
BUY
$27.17 - $31.97 $3.99 Million - $4.7 Million
146,887 Added 365.91%
187,030 $5.24 Million
Q2 2023

Aug 10, 2023
SELL
$28.34 - $33.63 $1.19 Million - $1.41 Million
-41,984 Reduced 51.12%
40,143 $1.26 Million
Q1 2023

May 09, 2023
SELL
$25.31 - $29.02 $2.83 Million - $3.24 Million
-111,652 Reduced 57.62%
82,127 $2.32 Million
Q4 2022

Feb 08, 2023
BUY
$21.94 - $26.24 $164,374 - $196,590
7,492 Added 4.02%
193,779 $5.06 Million
Q3 2022

Nov 04, 2022
BUY
$22.0 - $31.87 $509,322 - $737,822
23,151 Added 14.19%
186,287 $4.16 Million
Q2 2022

Jul 29, 2022
SELL
$26.4 - $30.54 $314,001 - $363,242
-11,894 Reduced 6.8%
163,136 $4.86 Million
Q1 2022

May 05, 2022
SELL
$23.07 - $27.99 $3.8 Million - $4.61 Million
-164,695 Reduced 48.48%
175,030 $4.6 Million
Q4 2021

Jan 21, 2022
SELL
$21.47 - $32.08 $1.31 Million - $1.95 Million
-60,903 Reduced 15.2%
339,725 $7.9 Million
Q3 2021

Nov 08, 2021
SELL
$23.37 - $32.13 $109,441 - $150,464
-4,683 Reduced 1.16%
400,628 $12.4 Million
Q2 2021

Aug 04, 2021
SELL
$18.78 - $25.15 $6.37 Million - $8.53 Million
-339,172 Reduced 45.56%
405,311 $9.94 Million
Q1 2021

May 10, 2021
SELL
$18.21 - $23.2 $1.38 Million - $1.76 Million
-75,876 Reduced 9.25%
744,483 $13.9 Million
Q4 2020

Feb 08, 2021
SELL
$15.39 - $22.1 $97,634 - $140,202
-6,344 Reduced 0.77%
820,359 $16.4 Million
Q3 2020

Nov 09, 2020
BUY
$16.16 - $20.66 $524,666 - $670,768
32,467 Added 4.09%
826,703 $13.7 Million
Q2 2020

Aug 05, 2020
BUY
$13.31 - $19.41 $2.59 Million - $3.77 Million
194,411 Added 32.41%
794,236 $15.4 Million
Q1 2020

May 06, 2020
BUY
$13.06 - $21.24 $26,799 - $43,584
2,052 Added 0.34%
599,825 $8.64 Million
Q4 2019

Jan 29, 2020
BUY
$17.29 - $21.74 $6.43 Million - $8.08 Million
371,614 Added 164.32%
597,773 $12.2 Million
Q3 2019

Nov 01, 2019
BUY
$19.51 - $24.28 $694,575 - $864,392
35,601 Added 18.68%
226,159 $4.42 Million
Q2 2019

Aug 09, 2019
SELL
$21.47 - $37.33 $1.3 Million - $2.25 Million
-60,364 Reduced 24.06%
190,558 $4.28 Million
Q1 2019

May 13, 2019
BUY
$28.4 - $36.49 $1.39 Million - $1.79 Million
49,089 Added 24.32%
250,922 $9.13 Million
Q4 2018

Feb 11, 2019
BUY
$27.94 - $44.61 $4.12 Million - $6.59 Million
147,616 Added 272.27%
201,833 $5.93 Million
Q3 2018

Oct 26, 2018
BUY
$38.6 - $46.12 $1.85 Million - $2.21 Million
47,966 Added 767.33%
54,217 $2.3 Million
Q2 2018

Aug 08, 2018
SELL
$40.56 - $51.36 $4.42 Million - $5.6 Million
-109,023 Reduced 94.58%
6,251 $257,000
Q1 2018

May 11, 2018
SELL
$53.61 - $67.26 $3.54 Million - $4.44 Million
-66,036 Reduced 36.42%
115,274 $6.68 Million
Q4 2017

Feb 06, 2018
BUY
$47.69 - $55.39 $4.41 Million - $5.12 Million
92,407 Added 103.94%
181,310 $10 Million
Q3 2017

Nov 07, 2017
BUY
$49.16 - $54.45 $4.37 Million - $4.84 Million
88,903
88,903 $4.52 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email